Načítá se...
Effect of statin treatment in obese selenium-supplemented mice lacking selenocysteine lyase
People with obesity are often dyslipidemic and prescribed statins to prevent cardiovascular events. A common side effect of statin use is myopathy. This could potentially be caused by the reduction of selenoproteins that curb oxidative stress, in turn, affecting creatine metabolism. We determined if...
Uloženo v:
| Vydáno v: | Mol Cell Endocrinol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8263501/ https://ncbi.nlm.nih.gov/pubmed/34052303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2021.111335 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|